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trug eluting stents (DES) have decreased
substantially the neointimal formation af-
ter percutaneous coronary intervention
(PCI). However, DES are not free from
neointimal hyperplasia (NIH) and stent thrombo-
sis, which are related to the delayed arterial healing
following DES implantation. The recently intro-
duced optical coherence tomography (OCT) en-
ables a detailed investigation of vessel healing. The
presence of peri-strut low intensity (PLI) has been
described as a potential marker of abnormal neoin-
timal healing (1,2). We investigated the late healing
characteristics of stents implanted over 3 years,
specifically the potential impact of PLI on NIH and
restenosis.
OCT imaging (M2, Lightlab Imaging, West-
ford, Massachusetts) was performed in 99 pa-
tients who were treated with bare-metal stents
(BMS), sirolimus-eluting stents (SES) (Cypher,
Cordis, Bridgewater, New Jersey), or paclitaxel-
eluting stents (PES) (Taxus, Boston Scientific,
Natick, Massachusetts) from September 2007 to
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ary 8, 2012, accepted February 9, 2012.ugust 2009. The inclusion criteria were stent im-
lanted in de novo lesion and time from index PCI
3 years. The exclusion criteria were left main, stent
hrombosis, or target lesion revascularization.
Cross-sectional images of the stented segments
ere analyzed at 1-mm intervals. PLI was defined
s homogenous low-intensity area around a stent
trut without significant signal attenuation be-
ind the area on a strut basis. The severity of PLI
n a cross-sectional basis was evaluated semi-
uantitatively by PLI score by the extent of PLI
ccupying the number of quadrants. Neointimal
hickness and malapposition of each strut, neo-
ntimal lipid pool, calcification, microvessel, and
CT-derived thin cap neoatheroma (OCT-
CNA) were also defined (Fig. 1A) (3). A total
f 3,365 OCT cross sections from 125 stents
ere assessed. After exclusion of overlapping
tents (2,197 struts [6.7%]) and side branches
1.5 mm (277 struts [0.8%]), a total of 30,302
truts (92.5%) and 3,053 cross sections were
ncluded in the analysis.
By the OCT strut-level analysis, PLI was most
ommon in BMS (19.4%), followed by PES
12.6%) and SES (6.0%; p 0.001) (Table 1). NIH
as higher in struts displaying PLI than struts
ithout PLI in all stents (p  0.001 for all).
nterestingly, the NIH thickness was 0.3 mm
ven in the BMS strut without PLI, and it was
0.5 mm in SES struts with PLI (Fig. 1B).
ignificant correlation between the severity of PLI
nd the degree of NIH was found in both the
ross-sectional and stent-level analyses (r  0.537
o 0.846; p  0.05) (Fig. 1B, Table 1). The
requency of OCT-TCNA per stent was 7.9% to
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115715.6% and not different between stent types (p 
nonsignificant) (Table 1). The severity of PLI
correlated with angiographic late loss in all groups
(r  0.407 to 0.583; p  0.05) (Fig. 1B, Table 1).
The presence of PLI in one quadrant of OCT
image was related to a 6.6- to 130.0-fold increase of
binary restenosis after adjustment for stent area
Figure 1. Representative Images of PLI and Impact of PLI on St
(A) Representative optical coherence tomography (OCT) ﬁndings
intensity adjacent to stent struts. PLI score is deﬁned as the num
the rightmost middle row. OCT-derived thin cap neoatheroma (O
(blue arrowhead) in 2 quadrants and a ﬁbrous cap thickness 
structures (pink arrows) visible in 1 cross-sectional image. Neo
arrowhead). Continued on the next page.(p  0.05) (Table 1).The vascular healing response of BMS implan-
tation is known to be initial regression of neointima
followed by a plateau at least up to 3 years, whereas
that of DES is a mild but continuous growth. Little
is known about the characteristics of late neointima.
Our study showed that PLI is a common finding
long after stent implantation and appears to be
Level Neointimal Thickness and Stent-Level Angiographic Late Lo
eointima. Peri-strut low intensity (PLI) (white arrows) is seen as h
of quadrants, 0 to 4, occupied by PLI. PLI may appear granular a
TCNA) was deﬁned as the presence of TCNA having an angle of s
m (pink arrows) in 3 consecutive images. Microvessels are smal
mal calciﬁcation is a well-delineated signal-poor mass with a sharprut- ss
of n omogenous lower
ber s shown by image in
CT- ignal-poor lipid pool
65 l vesicular tubular
inti border (blueinvolved in neointimal proliferation.
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1158The histopathology of PLI is still not known
well. PLI was correlated with the quality of the
neointima with different stent types (2,4,5). In
BMS PES
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ointimal thickness by PLI in strut level. The neointimal thickness over
I (red bars) in all stent types (all p  0.001). Even the neointimal thic
MS) without PLI (0.56  0.31 mm vs. 0.29  0.18 mm; p  0.0001).
late loss is shown in B2 and B3, respectively. PES  paclitaxel-elutinour study, the presence of PLI was the strongestfactor related to neointimal proliferation. Con-
sidering contribution of continuous inflamma-
tion, fibrin deposition, extracellular matrix accu-
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Figure 1. Continued
(B1) Distribution of ne stru
over struts without PL kne
of bare-metal stents (B Corr
plasia or angiographic g stmulation, or formation of neoatherosclerosis to
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1159the late neointimal growth, PLI may be the trace
of burnt-out neointimal growth or sustained
residual biological process occurring adjacent to
the stent.
The limitations of this study are its cross-
sectional nature and lack of neointimal histology.
The histological validation and serial examination
Table 1. Strut-Level, Cross-Sectional, and Stent-Level OCT Analy
BMS
Strut-level analysis
N 7,740
Neointimal thickness, mm 0.35 0.24
Uncovered strut 1.2 (90)
Malapposed strut 0 (3)
Strut with PLI 19.4 (1,501)
Cross-sectional level analysis
N 744
Stent area, mm2 7.60 2.67
Luminal area, mm2 4.45 1.66
Neointimal area, mm2 3.15 1.96
Neointimal area, % 40.3 15.2
No. of PLI 1.98 3.04
PLI score 0.78 1.19
Lipid pool 8.5 (63)
Microvessel 15.9 (118)
Calciﬁcation 2.4 (32)
Correlation between neointimal area and
no. of PLI
r  0.624
Stent-level analysis
N 32
Left anterior descending artery lesion 59.4 (19)
Imaged length, mm 17.5 5.7
Imaged length, %* 90.6 17.5
Stent length, mm 20.0 6.1
Volumetric obstruction, % 38.0 11.1
Volumetric obstruction, mm3 75.8 62.9
Any PLI within stent 87.5 (28)
Mean PLI score 0.76 0.83
Lipid pool 59.3 (19)
OCT-TCNA 15.6 (5)
Correlation between mean neointimal
area and strut with PLI
r  0.736
Angiographic binary restenosis and OCT
imaging
Mean PLI score per stent 6.612 (1.572–27.8
Stent area, mm2 0.922 (0.559–1.52
Values are mean  SD, n (%), or odds ratio (95% conﬁdence interval). The Krus
types, except *Pearson’s correlation coefﬁcient (p  0.05) and †odds ratio of m
BMS  bare-metal stent(s); OCT  optical coherence tomography; OCT-TCN
peri-strut low intensity; SES  sirolimus-eluting stent(s).they may have clinical implications among patients
undergoing stent implantation.
Reprint requests and correspondence: Dr. Hyeon-Cheol
Gwon, Department of Medicine, Cardiac and Vascular
Center, Samsung Medical Center, Sungkyunkwan Uni-
versity School of Medicine, 50 Irwon-dong, Gangnam-gu,
PES SES p Value
7,551 15,011
0.22 0.21 0.16 0.19 0.001
9.1 (686) 11.0 (1,644) 0.001
1.7 (132) 2.0 (305) 0.001
12.6 (955) 6.0 (907) 0.001
723 1586
7.89 2.36 6.85 2.00 0.001
6.04 2.37 5.59 2.05 0.001
1.85 1.61 1.26 1.48 0.001
23.7 19.4 17.9 18.8 0.001
1.26 2.57 0.57 1.82 0.001
0.50 0.95 0.24 0.77 0.001
4.1 (30) 3.0 (47) 0.001
2.4 (17) 1.9 (30) 0.001
0.7 (5) 0.3 (4) 0.001
r  0.425 r  0.593 0.001*
30 63
60.0 (18) 66.7 (42) 0.37
19.4 6.0 21.4 8.6 0.001
89.3 22.4 83.3 26.1 0.048
22.1 6.0 25.8 6.1 0.001
21.8 13.7 18.5 13.9 0.001
48.2 39.7 35.3 29.3 0.001
80.0 (24) 66.7 (42) 0.07
0.46 0.44 0.30 0.56 0.003
33.3 (10) 15.9 (10) 0.001
13.3 (4) 7.9 (5) 0.49
r  0.611 r  0.803 0.001*
50.93 (1.945–1333)† 129.9 (9.168–1839)†
0.460 (0.211–1.004) 0.988 (0.628–1.555)
allis test was used for comparison among stent types. p Value among 3 stent
ariate logistic regression analysis (p  0.05).
OCT-derived thin cap neoatheroma; PES  paclitaxel-eluting stent(s); PLI of our findings deserve further investigation because Seoul 135-710, Korea. E-mail: hcgwon62@gmail.com.sis
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